Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?

被引：19
作者：
Budgett, Rebecca F. [1 ]
Bakker, Geor [2 ]
Sergeev, Eugenia [2 ]
Bennett, Kirstie A. [2 ]
Bradley, Sophie J. [1 ,2 ]
机构：
[1] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Ctr Translat Pharmacol, Glasgow, Scotland
[2] Sosei Heptares, Cambridge, England
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
关键词：
GPCR; Alzheimer's disease; neurodegenerative disease; neuroinflammation; G protein coupled receptors; drug discovery; NEGATIVE ALLOSTERIC MODULATOR; AMYOTROPHIC-LATERAL-SCLEROSIS; LEVODOPA-INDUCED DYSKINESIA; IMPROVES FUNCTIONAL RECOVERY; DOPA-INDUCED DYSKINESIA; HUMAN SPINAL-CORD; MOUSE MODEL; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; GROUP-I;
D O I：
10.3389/fphar.2022.893422
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The type 5 metabotropic glutamate receptor, mGlu(5), has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical neurodegenerative disease models, novel allosteric modulators have been shown to improve cognitive performance and reduce disease-related pathology. A common pathological hallmark of neurodegenerative diseases is a chronic neuroinflammatory response, involving glial cells such as astrocytes and microglia. Since mGlu(5) is expressed in astrocytes, targeting this receptor could provide a potential mechanism by which neuroinflammatory processes in neurodegenerative disease may be modulated. This review will discuss current evidence that highlights the potential of mGlu(5) allosteric modulators to treat neurodegenerative diseases, including Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Furthermore, this review will explore the role of mGlu(5) in neuroinflammatory responses, and the potential for this G protein-coupled receptor to modulate neuroinflammation.
引用
收藏
页数：20
相关论文
共 216 条
[1]  
Abd-Elrahman KS, 2020, bioRxiv, DOI [10.1101/803262, 10.1101/803262, DOI 10.1101/803262]
[2]   A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice [J].
Abd-Elrahman, Khaled S. ;
Sarasija, Shaarika ;
Colson, Tash-Lynn L. ;
Ferguson, Stephen S. G. .
BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (08) :1769-1783
[3]   Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease [J].
Abd-Elrahman, Khaled S. ;
Ferguson, Stephen S. G. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 :235-254
[4]   Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner [J].
Abd-Elrahman, Khaled S. ;
Albaker, Awatif ;
de Souza, Jessica M. ;
Ribeiro, Fabiola M. ;
Schlossmacher, Michael G. ;
Tiberi, Mario ;
Hamilton, Alison ;
Ferguson, Stephen S. G. .
SCIENCE SIGNALING, 2020, 13 (662)
[5]   mGluR5 Contribution to Neuropathology in Alzheimer Mice Is Disease Stage-Dependent [J].
Abd-Elrahman, Khaled S. ;
Hamilton, Alison ;
Albaker, Awatif ;
Ferguson, Stephen S. G. .
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (02) :334-344
[6]   Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington's pathology in zQ175 mice [J].
Abd-Elrahman, Khaled S. ;
Ferguson, Stephen S. G. .
MOLECULAR BRAIN, 2019, 12 (1)
[7]   Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models [J].
Abd-Elrahman, Khaled S. ;
Hamilton, Alison ;
Vasefi, Maryam ;
Ferguson, Stephen S. G. .
MOLECULAR BRAIN, 2018, 11
[8]   D mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington's disease [J].
Abd-Elrahman, Khaled S. ;
Hamilton, Alison ;
Hutchinson, Shaunessy R. ;
Liu, Fang ;
Russell, Ryan C. ;
Ferguson, Stephen S. G. .
SCIENCE SIGNALING, 2017, 10 (510)
[9]  
Abou Farha Khalid, 2014, ISRN Psychiatry, V2014, P652750, DOI 10.1155/2014/652750
[10]   Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase [J].
Alexander, GM ;
Deitch, JS ;
Seeburger, JL ;
Del Valle, L ;
Heiman-Patterson, TD .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1666-1673
12345678910